Literature DB >> 12157905

Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence.

A Bideau, H Plauchu, G Brunet, J Robert.   

Abstract

Entities:  

Keywords:  Biology; Demographic Factors; Developed Countries; Diseases; Europe; France; Genetics; Geographic Factors; Hereditary Diseases; Mediterranean Countries; Migration; Population; Population Dynamics; Spatial Distribution; Western Europe

Mesh：

Year:  1989        PMID： 12157905

Source DB:  PubMed          Journal:  Popul


× No keyword cloud information.
  20 in total

Review 1.  Diagnosis and Treatment of Hereditary Hemorrhagic Telangiectasia.

Authors:  Cameron Grigg; Daniel Anderson; James Earnshaw
Journal:  Ochsner J       Date:  2017

Review 2.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment.

Authors:  Aditya Bharatha; Marie E Faughnan; Helen Kim; Tony Pourmohamad; Timo Krings; Pinar Bayrak-Toydemir; Ludmila Pawlikowska; Charles E McCulloch; Michael T Lawton; Christopher F Dowd; William L Young; Karel G Terbrugge
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

4.  Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years.

Authors:  T Krings; A Ozanne; S M Chng; H Alvarez; G Rodesch; P L Lasjaunias
Journal:  Neuroradiology       Date:  2005-09-01       Impact factor: 2.804

5.  Rendu-Osler disease: treatment with oestrogen/progestagen versus octreotide.

Authors:  Séverin Jeanneret; Loic Regazzoni; Bernard Favrat
Journal:  BMJ Case Rep       Date:  2011-02-23

6.  Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.

Authors:  Y H Kim; M-J Kim; S-W Choe; D Sprecher; Y J Lee; S P Oh
Journal:  J Thromb Haemost       Date:  2017-05-03       Impact factor: 5.824

7.  Hereditary Haemorrhagic Telangiectasia Cerebrospinal Localization in Adults and Children. Review of 39 cases.

Authors:  J Mahadevan; A Ozanne; Y Yoshida; Y C Weon; H Alvarez; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

8.  Hereditary haemorrhagic telangiectasia in children. Endovascular treatment of neurovascular malformations. Results in 31 patients.

Authors:  T Krings; S M Chng; A Ozanne; H Alvarez; G Rodesch; P L Lasjaunias
Journal:  Interv Neuroradiol       Date:  2005-06-17       Impact factor: 1.610

9.  Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations: results in 31 patients.

Authors:  T Krings; S M Chng; A Ozanne; H Alvarez; G Rodesch; P L Lasjaunias
Journal:  Neuroradiology       Date:  2005-09-15       Impact factor: 2.804

Review 10.  Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.

Authors:  Haneen Sadick; Maliha Sadick; Karl Götte; Ramin Naim; Frank Riedel; Gregor Bran; Karl Hörmann
Journal:  Wien Klin Wochenschr       Date:  2006-03       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.